Lucid Diagnostics Inc. Interest Expense
Lucid Diagnostics Inc. (LUCD) reported Interest Expense of $2.00 thousand for the 3-month period ending 2025-09-30, per its 10-Q filed 2025-11-12.
Financial Statements › Expense Statement › Interest Expense
us-gaap:InterestExpense · last filed 2025-11-12
- Lucid Diagnostics Inc. interest expense for the quarter ending 2025-09-30 was $2.00K, a 100.00% increase year-over-year.
- Lucid Diagnostics Inc. interest expense for the quarter ending 2025-06-30 was $6.00K, a 0.00% change year-over-year.
- Lucid Diagnostics Inc. interest expense for the quarter ending 2025-03-31 was $9.00K, a 25.00% decline year-over-year.
- Lucid Diagnostics Inc. interest expense for the quarter ending 2024-12-31 was $7.00K, a 36.36% decline year-over-year.
- Lucid Diagnostics Inc. interest expense for fiscal 2024 was $26.00K, a 93.75% decline from fiscal 2023.
- Lucid Diagnostics Inc. interest expense for fiscal 2023 was $416.00K, a 5100.00% increase from fiscal 2022.
- Lucid Diagnostics Inc. interest expense for fiscal 2022 was $8.00K.
| Period end | Interest Expense 3 month | Interest Expense 6 month | Interest Expense 9 month | Interest Expense 12 month |
|---|---|---|---|---|
| 2025-09-30 | $2.00K 10-Q · filed 2025-11-12 | $8.00K derived: sum of 2 quarters · filed 2025-11-12 | $16.00K 10-Q · filed 2025-11-12 | $24.00K derived: sum of 4 quarters · filed 2025-11-12 |
| 2025-06-30 | $6.00K 10-Q · filed 2025-08-12 | $14.00K 10-Q · filed 2025-08-12 | $22.00K derived: sum of 3 quarters · filed 2025-08-12 | $23.00K derived: sum of 4 quarters · filed 2025-11-12 |
| 2025-03-31 | $9.00K 10-Q · filed 2025-05-13 | $16.00K derived: sum of 2 quarters · filed 2025-05-13 | $17.00K derived: sum of 3 quarters · filed 2025-11-12 | $23.00K derived: sum of 4 quarters · filed 2025-11-12 |
| 2024-12-31 | $7.00K derived: 10-K 12 month − 10-Q 9 month · filed 2025-03-24 | $8.00K derived: sum of 2 quarters · filed 2025-11-12 | $14.00K derived: sum of 3 quarters · filed 2025-11-12 | $26.00K 10-K · filed 2025-03-24 |
| 2024-09-30 | $1.00K 10-Q · filed 2025-11-12 | $7.00K derived: sum of 2 quarters · filed 2025-11-12 | $19.00K 10-Q · filed 2025-11-12 | $30.00K derived: sum of 4 quarters · filed 2025-11-12 |
| 2024-06-30 | $6.00K 10-Q · filed 2025-08-12 | $18.00K 10-Q · filed 2025-08-12 | $29.00K derived: sum of 3 quarters · filed 2025-08-12 | $178.00K derived: sum of 4 quarters · filed 2025-08-12 |
| 2024-03-31 | $12.00K 10-Q · filed 2025-05-13 | $23.00K derived: sum of 2 quarters · filed 2025-05-13 | $172.00K derived: sum of 3 quarters · filed 2025-05-13 | $395.00K derived: sum of 4 quarters · filed 2025-05-13 |
| 2023-12-31 | $11.00K derived: 10-K 12 month − 10-Q 9 month · filed 2025-03-24 | $160.00K derived: sum of 2 quarters · filed 2025-03-24 | $383.00K derived: sum of 3 quarters · filed 2025-03-24 | $416.00K 10-K · filed 2025-03-24 |
| 2023-09-30 | $149.00K 10-Q · filed 2024-11-12 | $372.00K derived: sum of 2 quarters · filed 2024-11-12 | $405.00K 10-Q · filed 2024-11-12 | |
| 2023-06-30 | $223.00K 10-Q · filed 2024-08-12 | $257.00K 10-Q · filed 2024-08-12 | ||
| 2023-03-31 | $33.00K 10-Q · filed 2024-05-13 | |||
| 2022-12-31 | $8.00K 10-K · filed 2024-03-25 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| KORU Medical Systems, Inc. (KRMD) | United States | $0.151B | -106.78 |
| Profound Medical Corp. (PROF) | $0.206B | -7.37 | |
| Neuronetics, Inc. (STIM) | United States | $0.216B | -3.25 |
| Apyx Medical Corp (APYX) | United States | $0.120B | -21.85 |
| PRO DEX INC (PDEX) | United States | $0.234B | 13.64 |
| UTAH MEDICAL PRODUCTS INC (UTMD) | United States | $0.238B | 20.93 |
| Microbot Medical Inc. (MBOT) | $0.089B | -7.97 | |
| LENSAR, Inc. (LNSR) | United States | $0.087B | 2.02 |
| InfuSystem Holdings, Inc (INFU) | United States | $0.253B | 22.52 |
| SkinHealth Systems Inc. (SKIN) | United States | $0.086B | -3.17 |